The Worst of 2012: Progenics Pharmaceuticals

It's the end of 2012, and that means it's time to take a look back at the year in retrospect. We'll be reading through the naughty and nice lists (we've already checked them twice), counting down the 25 best-performing stocks and the 25 worst-performing stocks in the health care sector this year.

In this segment, Motley Fool health care analysts Brenton Flynn and Max Macaluso take a look at No. 1 on the naughty list, Progenics Pharmaceuticals (NASDAQ: PGNX  ) , and why this company deserves coal in its stocking.

While looking at 2012 performance is useful, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.


Read/Post Comments (1) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On December 10, 2012, at 3:40 PM, baldfatman wrote:

    Really? This report has nothing remotely new in it. And it's not an analysis, it's a regurgitation of the basic facts that you can find in the company PR from November.

    To say an analyst is reporting on this, and then have no actual analysis in the video is a waste of the viewers time. Seems like baiting the user for the click.

    bad job.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2146962, ~/Articles/ArticleHandler.aspx, 12/22/2014 2:58:00 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement